| |
| |
|
| Insider
Information: |
Trehu Elizabeth |
| Relationship: |
Chief Medical Officer |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
103,417 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$194,424 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
103,417 |
|
|
| Total
Value |
$194,424 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
9
|
|
Stock
price went up :
|
0
|
7
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
3.5
|
| Percentage
Gain/Loss : |
0.0%
|
 161.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Jounce Therapeutics Inc |
JNCE |
Chief Medical Officer |
2023-01-10 |
103,417 |
2018-03-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| JNCE |
Jounce Therapeutics Inc |
Chief Medical Officer |
• – – |
2023-01-10 |
4 |
S |
$1.12 |
$5,741 |
D/D |
(5,126) |
103,417 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Medical Officer |
• – – |
2023-01-09 |
4 |
S |
$1.10 |
$4,575 |
D/D |
(4,159) |
108,543 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Medical Officer |
• – – |
2022-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
27,500 |
112,702 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Medical Officer |
• – – |
2022-01-10 |
4 |
S |
$6.65 |
$35,764 |
D/D |
(5,378) |
85,202 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Medical Officer |
• – – |
2022-01-07 |
4 |
S |
$7.30 |
$21,937 |
D/D |
(3,005) |
90,580 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-03-31 |
4 |
AS |
$10.09 |
$83,747 |
D/D |
(8,300) |
93,585 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-03-31 |
4 |
OE |
$4.02 |
$33,366 |
D/D |
8,300 |
101,885 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-03-30 |
4 |
OE |
$4.02 |
$402 |
D/D |
100 |
93,685 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-03-30 |
4 |
AS |
$10.00 |
$1,000 |
D/D |
(100) |
93,585 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-03-29 |
4 |
AS |
$10.09 |
$51,459 |
D/D |
(5,100) |
93,585 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-03-29 |
4 |
OE |
$4.02 |
$20,502 |
D/D |
5,100 |
98,685 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
22,250 |
93,585 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-01-20 |
4 |
AS |
$12.01 |
$78,065 |
D/D |
(6,500) |
71,335 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-01-20 |
4 |
OE |
$4.02 |
$26,130 |
D/D |
6,500 |
77,835 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-01-08 |
4 |
S |
$7.00 |
$19,922 |
D/D |
(2,846) |
71,335 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-01-07 |
4 |
S |
$6.76 |
$16,576 |
D/D |
(2,452) |
74,181 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Medical Officer |
• – – |
2020-08-17 |
4 |
S |
$4.86 |
$2,206 |
D/D |
(454) |
77,377 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Medical Officer |
• – – |
2020-08-14 |
4 |
S |
$4.64 |
$8,070 |
D/D |
(1,728) |
76,633 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Medical Officer |
• – – |
2020-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
22,250 |
78,815 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Medical Officer |
• – – |
2020-01-07 |
4 |
S |
$7.78 |
$20,415 |
D/D |
(2,624) |
56,565 |
0 |
% |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Medical Officer |
• – – |
2019-08-16 |
4 |
S |
$3.92 |
$3,991 |
D/D |
(1,018) |
59,189 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Medical Officer |
• – – |
2019-08-15 |
4 |
S |
$4.00 |
$2,592 |
D/D |
(648) |
60,207 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Medical Officer |
• – – |
2019-08-14 |
4 |
S |
$4.10 |
$2,747 |
D/D |
(670) |
60,855 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Medical Officer |
• – – |
2019-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
22,250 |
61,525 |
0 |
- |
|
| JNCE |
Jounce Therapeutics Inc |
Chief Medical Officer |
• – – |
2018-08-13 |
4 |
A |
$0.00 |
$0 |
D/D |
14,400 |
39,275 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
